Pharma group Krka nine-month profit up 37% y/y to EUR 110m
Ljubljana, 16 November - The group around pharma company Krka reported EUR 928.3m in sales revenue for the first nine months on Thursday, a 9% improvement on 2016 and the best result in Krka's history. Net profit was up 37% to EUR 110.1m.
The rest of this news item is available to subscribers.
The news item consists of 1.245 characters (without spaces) or 267 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.